Delivery Order SPE2DE24D0013-SPE2D626F90F2
- Not listed
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a firm fixed-price delivery order (XPRSMVP-10) valued at $4,608.40 by the Defense Logistics Agency Medical Supply Chain on December 4, 2025, with an ultimate completion date of December 11, 2025. This delivery order, issued with no set-aside designation, represents a continuation of Cepheid's role as a primary federal supplier of molecular diagnostic systems and reagents. The contract is performed at Cepheid's Sunnyvale,...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $1,382.52 by the Defense Logistics Agency Medical Supply Chain on December 29, 2025, with an ultimate completion date of January 6, 2026. The contract, designated as XPRSMVP-10 and issued under a firm fixed-price arrangement with no set-aside designation, supports the agency's procurement of molecular diagnostic solutions. As a leading federal supplier of advanced diagnostic systems and reagents, Cepheid...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order valued at $6,448.40 by the Defense Logistics Agency Medical Supply Chain on January 7, 2026, with an ultimate completion date of January 14, 2026. This firm fixed-price delivery order, designated XPRSMVP-10, carries no set-aside designation and represents a continuation of Cepheid's role as a primary federal supplier of diagnostic solutions. The contract falls under the...
- Cepheid Inc., headquartered in Sunnyvale, California, has been awarded a delivery order valued at $2,304.20 by the Defense Logistics Agency Medical Supply Chain, with an ultimate completion date of January 7, 2026. This firm fixed-price delivery order, designated XPRSMVP-10, represents a continuation of Cepheid's ongoing role as a primary federal supplier of molecular diagnostic solutions. The contract carries no set-aside designation, reflecting Cepheid's competitive positioning in the...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a firm fixed-price delivery order valued at $17,162.40 by the Defense Logistics Agency Medical Supply Chain on October 20, 2025. This delivery order, designated XPRSMVP-10, is set to be completed by October 27, 2025, and represents an order for molecular diagnostic reagents and test kits designed for the GeneXpert diagnostic platform. The work will be performed at Cepheid's facility in Sunnyvale, California. This award reflects...
- Cepheid Inc., a Sunnyvale, California-based molecular diagnostics manufacturer, was awarded a delivery order valued at $2,765.04 on December 16, 2025, under the Defense Logistics Agency Medical Supply Chain contract vehicle. This firm fixed-price delivery order, designated XPRSMVP-10, is scheduled for completion by December 23, 2025, and will be performed at Cepheid's Sunnyvale facility. The award includes no small business set-aside designation, reflecting Cepheid's established competitive...
- Cepheid Inc., headquartered in Sunnyvale, California, has been awarded a firm fixed-price delivery order valued at $1,104.00 by the Defense Logistics Agency Medical Supply Chain, with an award date of November 25, 2025, and ultimate completion date of December 3, 2025. The delivery order, designated XPRSTREPA-10, represents procurement under a broader contracting vehicle and carries no set-aside designation. Cepheid is a specialized manufacturer of advanced molecular diagnostic systems and...
- Cepheid Inc., headquartered in Sunnyvale, California, has been awarded a delivery order (XPRSMVP-10) valued at $2,304.20 under a Defense Logistics Agency Medical Supply Chain Indefinite Delivery Contract. This firm fixed-price delivery order, issued on November 12, 2025, with an ultimate completion date of November 19, 2025, involves the supply of molecular diagnostic products, consistent with Cepheid's core business of providing advanced diagnostic solutions. The contract carries no set-aside...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $2,482.28 by the Defense Logistics Agency Medical Supply Chain on December 2, 2025, with an ultimate completion date of December 9, 2025. This firm fixed-price delivery order, designated as XPRSMVP-10, represents a continuation of Cepheid's role as a primary federal supplier of molecular diagnostic systems and reagents. The contract utilizes no set-aside designation, reflecting Cepheid's competitive...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order valued at $2,208 on December 3, 2025, by the Defense Logistics Agency's Medical Supply Chain division. The order is classified as a firm fixed-price delivery order with an ultimate completion date of December 10, 2025, and carries no set-aside designation. The contract is associated with Cepheid's broader federal contracting relationship, through which the company...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D626F90F2Delivery Order
Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic systems, was awarded a delivery order valued at $2,765.04 by the Defense Logistics Agency Medical Supply Chain on January 7, 2026, with ultimate completion by January 14, 2026. This firm fixed-price delivery order, designated XPRSMVP-10, requires no set-aside designation and is being performed at Cepheid's Sunnyvale headquarters. The contract falls under the company's established relationship with the Defense Logistics Agency Medical Supply Chain, through which the agency has issued numerous delivery orders for diagnostic testing supplies, test kits, and reagents to support federal healthcare operations. Cepheid has established itself as a primary federal supplier of molecular diagnostic solutions, particularly through its GeneXpert diagnostic platform, serving multiple defense and civilian federal agencies including the Department of Veterans Affairs, Indian Health Service, Defense Health Agency, and U.S. Coast Guard. The company holds substantial indefinite delivery contracts with the Veterans Affairs system, including a $32.8 million IDC with VISN 6 extending through September 2030 and a $6.7 million single-award contract with VISN 17, which demonstrate the company's critical role in supplying diagnostic reagents, test kits, and molecular testing capabilities across the federal healthcare system. All of Cepheid's federal contracts utilize firm fixed-price structures, reflecting the company's competitive positioning in the federal molecular diagnostics procurement market.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 1/6/26 |